Kadmon (NYSE:KDMN) Trading Up 4.6%

Shares of Kadmon Holdings Inc (NYSE:KDMN) were up 4.6% on Wednesday . The company traded as high as $3.85 and last traded at $3.90, approximately 60,730 shares traded hands during trading. A decline of 98% from the average daily volume of 2,876,260 shares. The stock had previously closed at $3.73.

A number of research analysts have weighed in on KDMN shares. Zacks Investment Research cut shares of Kadmon from a “buy” rating to a “hold” rating in a research report on Friday, March 13th. ValuEngine raised shares of Kadmon from a “sell” rating to a “hold” rating in a research report on Friday, January 3rd. Oppenheimer reaffirmed a “buy” rating and set a $8.00 price target on shares of Kadmon in a research report on Thursday, March 5th. Nomura started coverage on shares of Kadmon in a research report on Friday, January 10th. They set a “buy” rating and a $10.00 price target on the stock. Finally, HC Wainwright reaffirmed a “buy” rating and set a $25.00 price target on shares of Kadmon in a research report on Wednesday, February 26th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Kadmon presently has a consensus rating of “Buy” and an average target price of $11.65.

The stock has a market capitalization of $632.65 million, a price-to-earnings ratio of -8.29 and a beta of 2.07. The business’s 50-day simple moving average is $4.20 and its two-hundred day simple moving average is $3.85. The company has a debt-to-equity ratio of 0.16, a current ratio of 6.42 and a quick ratio of 6.40.

Kadmon (NYSE:KDMN) last posted its quarterly earnings data on Thursday, March 5th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.12. The company had revenue of $4.40 million for the quarter, compared to analyst estimates of $2.75 million. Kadmon had a negative net margin of 1,204.47% and a negative return on equity of 110.70%. As a group, sell-side analysts expect that Kadmon Holdings Inc will post -0.59 EPS for the current year.

In other news, Director Cynthia Schwalm acquired 31,000 shares of the company’s stock in a transaction dated Thursday, March 12th. The shares were bought at an average price of $3.24 per share, for a total transaction of $100,440.00. Following the completion of the purchase, the director now directly owns 9,307 shares of the company’s stock, valued at approximately $30,154.68. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Harlan Waksal acquired 16,000 shares of the company’s stock in a transaction dated Friday, March 13th. The shares were purchased at an average price of $2.93 per share, for a total transaction of $46,880.00. Following the purchase, the chief executive officer now directly owns 152,945 shares of the company’s stock, valued at $448,128.85. The disclosure for this purchase can be found here. Insiders have bought 59,600 shares of company stock worth $191,168 in the last quarter. Insiders own 2.85% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Amalgamated Bank raised its stake in shares of Kadmon by 16.1% during the fourth quarter. Amalgamated Bank now owns 27,270 shares of the company’s stock valued at $124,000 after purchasing an additional 3,785 shares during the period. Meeder Asset Management Inc. raised its stake in shares of Kadmon by 49.1% during the fourth quarter. Meeder Asset Management Inc. now owns 14,843 shares of the company’s stock valued at $68,000 after purchasing an additional 4,888 shares during the period. ProShare Advisors LLC raised its stake in shares of Kadmon by 43.1% during the fourth quarter. ProShare Advisors LLC now owns 21,217 shares of the company’s stock valued at $96,000 after purchasing an additional 6,386 shares during the period. Bank of Montreal Can raised its stake in shares of Kadmon by 54.0% during the fourth quarter. Bank of Montreal Can now owns 23,744 shares of the company’s stock valued at $107,000 after purchasing an additional 8,329 shares during the period. Finally, California State Teachers Retirement System raised its stake in shares of Kadmon by 5.6% during the third quarter. California State Teachers Retirement System now owns 211,690 shares of the company’s stock valued at $533,000 after purchasing an additional 11,236 shares during the period. Institutional investors own 80.93% of the company’s stock.

About Kadmon (NYSE:KDMN)

Kadmon Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. The company markets and distributes products in various therapeutic areas, including ribavirin products for chronic hepatitis C virus infection; and distributes products in various therapeutic areas, including tetrabenazine for the treatment of chorea associated with Huntington's disease.

Further Reading: What is the cash asset ratio?

Receive News & Ratings for Kadmon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadmon and related companies with MarketBeat.com's FREE daily email newsletter.